PFM Health Sciences, LP - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$11,858,487
-74.4%
318,948
+1.1%
0.52%
-66.8%
Q4 2021$46,273,000
-13.0%
315,449
+5.0%
1.58%
+0.8%
Q3 2021$53,169,000
+14.7%
300,545
+4.7%
1.56%
+7.6%
Q2 2021$46,367,000
-12.6%
287,046
-7.3%
1.45%
-10.4%
Q1 2021$53,065,000
-4.6%
309,780
+22.3%
1.62%
-17.2%
Q4 2020$55,636,000
-17.5%
253,306
-37.6%
1.96%
-37.2%
Q3 2020$67,444,000
+100.8%
406,168
-5.8%
3.12%
+214.3%
Q3 2019$33,589,000
+281.3%
431,123
+258.8%
0.99%
+408.7%
Q1 2019$8,808,000120,1660.20%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders